Search

Start typing to see results...

Today Market

Stock Performance

Today Market

Today's High

77,357.97

Todday's Low

76,988.22

Open at

77,128.05

Previous Close

76,933.59

Volumes

Avg Price

330.92

Historical Performance

News

31 Jul 26
Strides Pharma Science’s revenue increased 13% year-over-year to Rs 12,654 million
Strides Pharma Science Ltd (BSE: 532531, NSE: STAR) announced its consolidated financial results for the quarter ended June 30, 2026, reporting revenue of Rs 12,654 million, a 13% year-over-year increase, with Ex-US markets growing 17% year-over-year to Rs 5,875 million.
31 Jul 26
Strides Pharma Science consolidated net profit rises 57.52% in the June 2026 quarter
Net profit of Strides Pharma Science rose 57.52% to Rs 156.91 crore in the quarter ended June 2026 as against Rs 99.
25 Jul 26
Strides Pharma Science to convene board meeting
Strides Pharma Science will hold a meeting of the Board of Directors of the Company on 31 July 2026.
21 Jul 26
Strides Pharma Science to convene AGM
Strides Pharma Science announced that the 35th Annual General Meeting(AGM) of the company will be held on 14 August 2026.

Historical Prices

Share Price Chart

Historical Share Price

Date Open Price (₹) High Price(₹) Low Price(₹) Close Price(₹) Total Volume No of Trades Net Turnover(₹) NIFTY
28-08-26 984.00 1026.50 982.10 1019.90 435651 16784 437675455.20 24175.65
27-08-26 982.90 994.40 978.90 983.00 94124 6645 92727259.00 24090.85
26-08-26 986.60 999.40 981.00 982.90 97630 8653 96490665.00 24207.75
25-08-26 999.00 1001.90 976.00 986.60 209006 9937 206168915.30 24334.55
24-08-26 989.40 999.00 974.30 993.60 220560 14425 217834294.00 24219.05
21-08-26 998.00 1003.00 970.60 986.20 341043 17628 335923900.40 24252.00
20-08-26 986.50 1056.00 970.00 993.00 4948966 161208 4993989683.00 24231.85
19-08-26 949.10 965.00 931.30 957.50 346391 24520 329046209.10 24078.30
18-08-26 984.80 984.80 944.10 949.10 242012 14337 231904880.40 24154.90
17-08-26 965.00 992.90 965.00 987.10 165364 12855 162234060.90 24287.65

Fundamentals

Company Valuation

Market Cap (₹cr)

9055.51

PE Ratio

50.28

PB Ratio

2.76

Dividend Yield

0.51

ROE

2.27

ROCE

4.81

Book Value (₹)

356.2353295

Face Value (₹)

10

Share Holding Pattern

Category of Shareholder No of Shares % Share Holdings Demat Shares Share Holders
plus  Promoter & Group
plus  Foreign
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
plus  Indian
Bodies Corporate-Indian (Promoter & Group) 734 0.00 734 1
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 3908899 4.24 3908899 10
Partnership Firms-Indian (Promoter & Group) 21309635 23.12 21309635 2
Persons Acting in Concert 0 0.00 0 0
Trusts 510000 0.55 510000 2
Others 0 0.00 0 0
Sub Total 25729268 27.91 25729268 15
Total ShareHolding for Promoter & Group 25729268 27.91 25729268 15
plus   Publice Share Holding
plus  Institution
Government(Central / State) 8125 0.01 8125 1
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 9025 0.01 7999 7
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 26171427 28.39 26171427 229
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 4595627 4.99 4595627 4
Mutual Funds / UTI 8043509 8.73 8043509 11
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 1553596 1.69 1553596 10
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 40381309 43.81 40380283 262
plus  Non Institution
Bodies Corporate 3498894 3.80 3497776 863
Clearing Members 689 0.00 689 3
Directors & their Relatives 110946 0.12 110946 9
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 1941186 2.11 1939879 1173
Foreign Non Institution Other 21000 0.02 21000 1
Hindu Undivided Families 1159881 1.26 1159881 1807
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 6941660 7.53 6941660 89
Individuals holding nominal share capital up to Rs. 1 lakh 11882223 12.89 11826346 89337
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 1065 0.00 1065 6
Others 504593 0.55 504593 1291
Sub Total 26062137 28.28 26003835 94579
Total Public Shareholding 66443446 72.09 66384118 94841
Total of Promoter & Public ShareHolding 92172714 100.00 92113386 94856
plus  Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total 92172714 100.00 92113386 94856

Financials (₹ in cr)

Year EndMar 2026Mar 2025Mar 2024Mar 2023Mar 2022
Net Sales4,858.684,565.343,890.133,688.393,070.25
OPM (%)14.329.251.91-7.30-13.31
OP695.53422.2674.25-269.17-408.69
Other Income150.7158.7239.7090.33131.99
PBIDT1,049.63928.03379.07218.19-242.76
INTEREST178.55248.85280.22261.14176.74
PBDT871.09679.1898.85-42.95-419.50
PBT641.84551.58-303.84-303.23-896.34
EO-26.8464.66-189.05-17.03-243.83
PBT after EO668.69486.92-114.79-286.20-652.51
TAXES94.1777.5229.11-55.30-178.26
PAT556.193,593.46-70.61-202.64-460.21
EPS60.34390.55-7.76-22.49-51.28
Raw Material32.0932.3329.5939.0935.53
Power and Fuel1.371.271.932.332.33
Employee Cost19.1218.9018.9519.8521.07
Other Manufacturing Expenses0.000.000.000.000.00
Selling and Administration Expenses12.8611.3510.6114.2718.83
Miscellaneous Expenses-0.760.900.971.001.66
Revenue (Growth %) 6.4317.365.4720.13-7.41
PBIDT (Growth %)13.10144.8273.73-189.88-138.42
PAT (Growth %) -84.52-5,189.01-65.15-55.97-271.44
PBIDT (Margin %)21.6020.339.745.92-7.91
PAT (Margin %) 11.4578.71-1.82-5.49-14.99

Balance Sheet (₹ in cr)

Particulars (Sources Of Funds)Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021
Share Capital 92.1792.1691.9090.3089.7989.68
Reserves Total 3191.353100.573435.583347.653316.493158.38
Equity Share Warrants0.000.000.0017.100.000.00
Equity Application Money0.000.000.120.000.410.00
Total Shareholders Funds3283.523192.733527.603455.053406.693248.06
Secured Loans 994.581023.941527.051253.771122.37791.99
Unsecured Loans 189.66178.29160.68160.43161.55125.47
Total Debt1184.241202.231687.731414.201283.92917.46
Other Liabilities80.6352.8347.4033.3234.18211.24
Total Liabilities4548.394447.795262.734902.574724.794376.76
APPLICATION OF FUNDS :
Gross Block 1579.601493.321459.651196.451142.011099.30
Less : Accumulated Depreciation 794.77726.39712.44599.89525.11454.80
Less:Impairment of Assets0.000.000.000.000.000.00
Net Block 784.83766.93747.21596.56616.90644.50
Lease Adjustment0.000.000.000.000.000.00
Capital Work in Progress181.30105.68107.4955.3855.72110.67
Producing Properties0.000.000.000.000.000.00
Investments 1868.281847.692363.592491.772399.762394.65
Current Assets, Loans & Advances
Inventories 580.27431.71498.07490.76513.06689.08
Sundry Debtors 1521.281452.931565.041307.781296.32821.67
Cash and Bank Balance40.6830.50115.1085.5814.4573.04
Loans and Advances 231.36230.36232.97242.28151.42160.07
Total Current Assets2373.592145.512411.172126.401975.251743.86
Less : Current Liabilities and Provisions
Current Liabilities 825.03560.06618.82702.17688.63818.75
Provisions 22.2923.1020.3315.0020.4525.82
Total Current Liabilities & Provisions847.32583.16639.14717.17709.08844.58
Net Current Assets1526.271562.351772.031409.241266.17899.28
Miscellaneous Expenses not written off 0.000.000.000.000.000.00
Deferred Tax Assets131.03139.22158.09133.65122.18118.14
Deferred Tax Liability16.9838.9939.1538.4144.6042.93
Net Deferred Tax114.05100.23118.9495.2477.5875.21
Other Assets73.6664.91153.47254.39308.65252.45
Total Assets4548.394447.795262.724902.584724.784376.75
Contingent Liabilities165.68204.90773.111313.041705.671792.04

Cash Flow (₹ in cr)

Yearly Cash FlowMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Financing Activities 250.7310.8293.34-370.32-198.93
Investing Activities 18.78-182.58-68.69-137.59-69.07
Net Cash Flow -13.1869.9810.65-86.429.84
Operating Activities -282.69241.74-14.01421.48277.85

Corporate Actions

DateCorporate ActionInformation
No Corporate Actions Announced

Board of Directors

Chairman & Chief Executive Officer
AK
Arun Kumar
Chairman & Non Executive Dir.
Executive
Functional Directors
BK
Badree Komandur
Group CEO & Executive Director
Exec.
VSR
VENKATA SEETHARAMA RAJU PAKALAPATI
Executive Director & COO
Exec.
Independent Directors
KS
Kausalya Santhanam
Independent Non Exe. Director
Ind.
MMA
Mukta Malik Arora
Independent Non Exe. Director
Ind.
SC
Subir Chakraborty
Independent Non Exe. Director
Ind.
HRK
Homi R Khusrokhan
Independent Non Exe. Director
Ind.
AH
Ameet Hariani
Independent Non Exe. Director
Ind.
Other Officials
MR
Manjula Ramamurthy
Company Sec. & Compli. Officer
Board

Frequently Asked Questions

What is the NSE symbol and BSE code for Strides Pharma Science Ltd?

Strides Pharma Science Ltd trades on NSE under STAR and on BSE under code 532531. The ISIN is INE939A01011 and the face value is Rs 10.

What is the share price of Strides Pharma Science Ltd today? +

As of 29 August 2026, Strides Pharma Science Ltd trades at Rs 1,019.90, a change of 36.90 (3.75%) on the day. Prices are live and subject to change.

What is the market capitalisation of Strides Pharma Science Ltd? +

As of 29 August 2026, Strides Pharma Science Ltd has a market cap of about Rs 9055.51 crore. This figure is live and moves with the share price.

Is Strides Pharma Science Ltd profitable? +

In March 2026, Strides Pharma Science Ltd reported a profit after tax of Rs 556.19 crore. The wording switches to "a net loss of Rs X crore" when the figure is negative.

What is the PE ratio of Strides Pharma Science Ltd? +

: As of 29 August 2026, the PE (TTM) for Strides Pharma Science Ltd is 50.28 and the price-to-book ratio is 2.76. When the PE shows zero, state that PE TTM is currently not applicable and give the PB only.

Does Strides Pharma Science Ltd pay a dividend? +

As of 29 August 2026, the dividend yield for Strides Pharma Science Ltd is 0.51%. The wording switches to "does not currently pay a dividend" when the yield is zero.

What is the shareholding pattern of Strides Pharma Science Ltd? +

As of the latest disclosed pattern, promoters hold 27.91% of Strides Pharma Science Ltd. Public shareholding is 72.09%, including mutual funds at 8.73% and foreign institutional investors at 28.39%.

What were the latest annual financials of Strides Pharma Science Ltd? +

In March 2026, Strides Pharma Science Ltd reported net sales of Rs 4,858.68 crore, revenue growth of 6.43%, and earnings per share of Rs 60.34.